Builders FirstSource Valuation
Is BLDR * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BLDR * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BLDR * (MX$3542) is trading below our estimate of fair value (MX$4286.53)
Significantly Below Fair Value: BLDR * is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BLDR *?
Other financial metrics that can be useful for relative valuation.
What is BLDR *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$20.03b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.4x |
Enterprise Value/EBITDA | 9.5x |
PEG Ratio | 14.8x |
Price to Earnings Ratio vs Peers
How does BLDR *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 41.1x | ||
LAMOSA * Grupo Lamosa. de | 71.6x | 38.6% | Mex$40.8b |
CERAMIC B Internacional de Cerámica. de | 50.1x | n/a | Mex$13.5b |
ELEMAT * Elementia Materiales S. A. B. de C. V | 16x | n/a | Mex$11.5b |
AGUA * Grupo Rotoplas. de | 26.9x | 16.7% | Mex$10.0b |
BLDR * Builders FirstSource | 14.3x | 1.0% | Mex$20.0b |
Price-To-Earnings vs Peers: BLDR * is good value based on its Price-To-Earnings Ratio (14.3x) compared to the peer average (49.5x).
Price to Earnings Ratio vs Industry
How does BLDR *'s PE Ratio compare vs other companies in the Global Building Industry?
Price-To-Earnings vs Industry: BLDR * is good value based on its Price-To-Earnings Ratio (14.3x) compared to the Global Building industry average (17.8x).
Price to Earnings Ratio vs Fair Ratio
What is BLDR *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 14.3x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate BLDR *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$3,542.00 | Mex$4,172.97 +17.8% | 10.1% | Mex$4,660.07 | Mex$3,394.62 | n/a | 16 |
Oct ’25 | Mex$3,806.61 | Mex$3,856.79 +1.3% | 10.3% | Mex$4,462.64 | Mex$3,279.07 | n/a | 15 |
Sep ’25 | Mex$3,434.15 | Mex$3,588.04 +4.5% | 7.7% | Mex$4,315.98 | Mex$3,213.33 | n/a | 15 |
Aug ’25 | Mex$2,958.30 | Mex$3,677.84 +24.3% | 8.7% | Mex$4,284.92 | Mex$3,260.27 | n/a | 16 |
Jul ’25 | Mex$2,516.00 | Mex$3,650.00 +45.1% | 9.2% | Mex$4,389.88 | Mex$3,174.50 | n/a | 17 |
Jun ’25 | Mex$2,686.00 | Mex$3,463.86 +29.0% | 8.2% | Mex$4,103.62 | Mex$2,967.49 | n/a | 17 |
May ’25 | n/a | Mex$3,693.74 0% | 8.2% | Mex$4,146.69 | Mex$2,998.64 | n/a | 17 |
Apr ’25 | n/a | Mex$3,638.42 0% | 9.0% | Mex$4,208.30 | Mex$2,777.48 | n/a | 18 |
Mar ’25 | Mex$3,400.09 | Mex$3,656.31 +7.5% | 9.9% | Mex$4,274.55 | Mex$2,821.20 | n/a | 18 |
Feb ’25 | Mex$3,022.39 | Mex$3,144.56 +4.0% | 11.5% | Mex$3,785.91 | Mex$2,357.59 | n/a | 18 |
Jan ’25 | Mex$2,882.15 | Mex$2,900.20 +0.6% | 12.0% | Mex$3,397.72 | Mex$2,327.44 | n/a | 17 |
Dec ’24 | Mex$2,391.21 | Mex$2,765.49 +15.7% | 13.1% | Mex$3,439.40 | Mex$2,201.22 | n/a | 16 |
Nov ’24 | Mex$2,103.20 | Mex$2,980.59 +41.7% | 12.6% | Mex$3,918.71 | Mex$2,404.66 | Mex$3,425.21 | 15 |
Oct ’24 | Mex$2,222.90 | Mex$2,946.46 +32.6% | 12.3% | Mex$3,751.29 | Mex$2,301.93 | Mex$3,806.61 | 15 |
Sep ’24 | Mex$2,347.70 | Mex$2,946.46 +25.5% | 12.3% | Mex$3,751.29 | Mex$2,301.93 | Mex$3,434.15 | 15 |
Aug ’24 | Mex$2,400.00 | Mex$2,296.24 -4.3% | 18.4% | Mex$2,957.83 | Mex$1,622.58 | Mex$2,958.30 | 14 |
Jul ’24 | Mex$2,325.70 | Mex$2,153.56 -7.4% | 16.4% | Mex$2,740.90 | Mex$1,644.54 | Mex$2,516.00 | 14 |
Jun ’24 | Mex$2,075.00 | Mex$2,209.11 +6.5% | 15.9% | Mex$2,850.46 | Mex$1,710.28 | Mex$2,686.00 | 14 |
May ’24 | n/a | Mex$1,711.93 0% | 13.0% | Mex$2,075.46 | Mex$1,389.66 | n/a | 14 |
Apr ’24 | Mex$1,584.47 | Mex$1,702.90 +7.5% | 12.4% | Mex$2,084.92 | Mex$1,395.99 | n/a | 14 |
Mar ’24 | Mex$1,438.95 | Mex$1,661.59 +15.5% | 14.2% | Mex$2,081.83 | Mex$1,285.31 | Mex$3,400.09 | 14 |
Feb ’24 | Mex$1,497.85 | Mex$1,476.03 -1.5% | 11.7% | Mex$1,783.04 | Mex$1,107.36 | Mex$3,022.39 | 14 |
Jan ’24 | Mex$1,261.00 | Mex$1,529.49 +21.3% | 10.8% | Mex$1,866.26 | Mex$1,159.04 | Mex$2,882.15 | 14 |
Dec ’23 | n/a | Mex$1,513.34 0% | 10.3% | Mex$1,834.77 | Mex$1,274.68 | Mex$2,391.21 | 14 |
Nov ’23 | Mex$1,200.00 | Mex$1,844.12 +53.7% | 14.3% | Mex$2,513.40 | Mex$1,508.04 | Mex$2,103.20 | 14 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.